Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals announced on Wednesday, 5 June, that the company has entered into a non-exclusive patent licensing agreement with Takeda for commercialising Vonoprazan in India.  The company will market Vonoprazan under its own trademark, and it is a novel potassium-competitive acid blocker (P-CAB0, which is used for treating acid-related disorders and gastroesophageal reflux disease. Aman…